NasdaqCM - Delayed Quote USD
Veru Inc. (VERU)
0.5082
-0.0010
(-0.20%)
At close: May 30 at 4:00:01 PM EDT
0.5100
+0.00
+(0.35%)
After hours: May 30 at 7:59:41 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | -- | 1 |
Avg. Estimate | -0.05 | -0.06 | 0 | -0.24 |
Low Estimate | -0.05 | -0.06 | 0 | -0.24 |
High Estimate | -0.05 | -0.06 | 0 | -0.24 |
Year Ago EPS | -0.08 | -0.05 | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 3 | 4 |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | 3.95M | 6.66M | 16.89M | -- |
Sales Growth (year/est) | -100.00% | -100.00% | -100.00% | 0.00% |
Earnings History
Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
---|---|---|---|---|
EPS Est. | -0.06 | -0.08 | -0.08 | -0.05 |
EPS Actual | -0.08 | -0.05 | -0.07 | -0.06 |
Difference | -0.02 | 0.03 | 0.01 | -0.01 |
Surprise % | -26.67% | 35.00% | 10.87% | -20.60% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | -0.05 | -0.06 | 0 | -0.24 |
7 Days Ago | -0.05 | -0.05 | 0 | 0 |
30 Days Ago | -0.05 | -0.05 | 0 | 0 |
60 Days Ago | -0.05 | -0.05 | 0 | 0 |
90 Days Ago | -0.05 | -0.05 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | 1 | -- | 1 |
Down Last 30 Days | -- | 1 | -- | 1 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
VERU | 34.21% | -15.38% | -- | -- |
S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Upgrades & Downgrades
Reiterates | HC Wainwright & Co.: Buy to Buy | 1/2/2025 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 12/20/2024 |
Reiterates | Oppenheimer: Outperform to Outperform | 11/5/2024 |
Initiated | B. Riley Securities: Buy | 5/14/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 5/13/2024 |
Maintains | HC Wainwright & Co.: Buy to Buy | 5/6/2024 |
Related Tickers
ASBP Aspire Biopharma Holdings, Inc.
0.4301
-28.60%
SPRO Spero Therapeutics, Inc.
2.5000
+17.37%
PLRZ Polyrizon Ltd.
0.9131
-26.95%
ALZN Alzamend Neuro, Inc.
3.8300
-29.60%
INAB IN8bio, Inc.
0.1482
-3.39%
BLRX BioLineRx Ltd.
5.25
+35.31%
IMNN Imunon, Inc.
2.4900
+25.13%
ORIC ORIC Pharmaceuticals, Inc.
8.17
+2.51%
IFRX InflaRx N.V.
0.8025
-5.60%
RCKT Rocket Pharmaceuticals, Inc.
2.5100
-4.20%